June 13, 2018—Newly introduced legislation would demand accountability and transparency from drug manufacturers participating in the 340B drug pricing program. The bill, sponsored by Rep. Doris Matsui (D-Calif.), is the most significant pro-340B proposal in nearly a decade. Under the Matsui bill, known as the Stretching Entity Resources for Vulnerable Communities (SERV … [Read more...]
Faces of 340B: A Story About Family
June 11, 2018 – For Sandy Clark, the 340B program is personal. She was inspired to become a 340B coordinator due to the experience of one special patient in particular – her own son. Sandy’s son was diagnosed with Hodgkin’s lymphoma in 2005, just a month before graduating from high school. At the time, Meadville Medical Center in northwestern Pennsylvania did not have the … [Read more...]
Faces of 340B: “We Stand in that Gap”
May 24, 2018 – For Chuck Beams, it was one patient in particular who made him realize just how crucial the 340B program is to uninsured and underinsured patients with serious medical conditions. The patient from Auburn, Ala., required tens of thousands of dollars in infusions and other costly care for his cancer and had no idea how he was going to obtain the treatments until he … [Read more...]
340B Hospitals Provide Higher Levels of Uncompensated Care, New Study Confirms
May 23, 2018—A new report published in the Journal of the American Medical Association (JAMA) Internal Medicine finds that 340B hospitals have a higher uncompensated care burden than non-340B hospitals and operate at lower margins. This new study echoes the findings of a recent report by L&M Policy Research, which found 340B hospitals provide 60 percent of all uncompensated … [Read more...]
Quit Stalling Key 340B Rule, Healthcare Providers Tell HHS
May 23, 2018—Hospitals are telling the U.S. Department of Health and Human Services (HHS) that it should stop delaying important 340B regulations to police drug manufacturer pricing and overcharges. In letters to the government, major hospital groups said the time for delay is over and urged the Trump administration to enforce the rules immediately. Public comments on HHS’s … [Read more...]
Members of Congress Aim to Drum up Support for 340B
May 16, 2018—Two stalwart supporters of the 340B program in Congress appealed today for more help engaging lawmakers and more of the public in efforts to protect the drug discount program. Reps. David McKinley (R-W.V.) and Doris Matsui (D-Calif.) spoke at a May 16 Capitol Hill briefing sponsored by Vizient, a healthcare services company that contracts with 340B hospitals … [Read more...]
Patients, Consumers, and Providers Urge Congress to Support 340B
May 15, 2018—A broad coalition of patient and consumer advocacy groups urged congressional leaders yesterday to join them “in supporting, not weakening, the 340B program.” The 61 groups made the appeal as Congress debates a variety of proposals to alter the program and on the eve of a Senate committee hearing this morning on the drug discount program. In their May 14 letter, … [Read more...]